Total Visits

Views
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. 48

Total Visits Per Month

December 2018January 2019February 2019March 2019April 2019May 2019June 2019
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. 4 5 2 0 2 8 3

File Visits

Views
12885_2018_Article_4442.pdf 26

Top country views

Views
United States 19
Egypt 6
United Kingdom 3
Pakistan 2
Canada 1
Germany 1
Russia 1

Top cities views

Views
Ashburn 6
Woodbridge 4
Fairfield 3
Islamabad 2
Mountain View 2
Cambridge 1
Houston 1
Wilmington 1